In March 2021, during the height of the COVID-19 pandemic, Contract Pharma wrote an article detailing Jubilant HollisterStier’s contract with Eli Lilly to manufacture a therapeutic COVID-19 treatment. This contract is one example of how JHS assisted in producing both treatments and vaccines during the pandemic.
Life Science Washington, an independent, non-profit trade association serving the life sciences industry in the state of Washington, notes Jubilant HollisterStier's win as the Association of Washington Business (AWB) 2024 Manufacturer of the Year.
Jubilant HollisterStier CMO is making significant strides in expanding its capabilities to meet global demand for complex formulations and sterile injectables. In this interview with Contract Pharma, CEO Chris Preti shares insights into the company’s ongoing...
In June of 2023, Chris Preti, CEO of Jubilant HollisterStier CMO, met with Grant Playter, associate editor of Pharmtech.com, at the 2023 DCAT Week conference. Topics of discussion include operations and the strategic vision at Jubliant HollisterStier, the current...
